Suranyi MG - Search Results

1

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease.

Roger SD, Suranyi MG, Walker RG, Disney A, Isbel NM, Kairaitis L, Pollock CA, Brown FG, Chow J, Truman MI, Ulyate KA; COMFORT study group. Roger SD, et al. Among authors: suranyi mg. Curr Med Res Opin. 2008 Aug;24(8):2181-7. doi: 10.1185/03007990802240552. Epub 2008 Jun 18. Curr Med Res Opin. 2008. PMID: 18565240 Clinical Trial.

2

Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease.

Suranyi MG, Lindberg JS, Navarro J, Elias C, Brenner RM, Walker R. Suranyi MG, et al. Am J Nephrol. 2003 Mar-Apr;23(2):106-11. doi: 10.1159/000068041. Am J Nephrol. 2003. PMID: 12481149

3

Review: anticoagulation for haemodialysis.

Suranyi M, Chow JS. Suranyi M, et al. Nephrology (Carlton). 2010 Jun;15(4):386-92. doi: 10.1111/j.1440-1797.2010.01298.x. Nephrology (Carlton). 2010. PMID: 20609088 Review.

4

Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study.

Canaud B, Mingardi G, Braun J, Aljama P, Kerr PG, Locatelli F, Villa G, Van Vlem B, McMahon AW, Kerloëguen C, Beyer U; STRIATA Study Investigators. Canaud B, et al. Nephrol Dial Transplant. 2008 Nov;23(11):3654-61. doi: 10.1093/ndt/gfn320. Epub 2008 Jun 27. Nephrol Dial Transplant. 2008. PMID: 18586762 Free PMC article. Clinical Trial.

5

The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator.

Chan R, Brooks R, Erlich J, Chow J, Suranyi M. Chan R, et al. Clin J Am Soc Nephrol. 2009 Jan;4(1):160-7. doi: 10.2215/CJN.01520308. Epub 2008 Nov 5. Clin J Am Soc Nephrol. 2009. PMID: 18987298 Free PMC article.

6

Needle-stick injury: a novel intervention to reduce the occupational health and safety risk in the haemodialysis setting.

Chow J, Rayment G, Wong J, Jefferys A, Suranyi M. Chow J, et al. J Ren Care. 2009 Sep;35(3):120-6. doi: 10.1111/j.1755-6686.2009.00093.x. J Ren Care. 2009. PMID: 19689693

7

Measuring kidney disease-related loss in samples of predialysis and dialysis patients: validating the kidney disease loss scale.

Chan R, Brooks R, Gallagher M, Erlich J, Snelling P, Chow J, Suranyi M. Chan R, et al. Clin J Am Soc Nephrol. 2010 Jul;5(7):1249-54. doi: 10.2215/CJN.08361109. Epub 2010 May 24. Clin J Am Soc Nephrol. 2010. PMID: 20498243 Free PMC article.

8

Change process during synchronised conversion to a once-monthly erythropoiesis-stimulating agent (ESA) administration at a single satellite haemodialysis unit.

Chow JS, Rayment G, Britos V, Cleland B, Suranyi M. Chow JS, et al. J Ren Care. 2012 Dec;38(4):191-201. doi: 10.1111/j.1755-6686.2012.00318.x. Epub 2012 Aug 25. J Ren Care. 2012. PMID: 22925087

9

Examining internet-delivered cognitive behaviour therapy for patients with chronic kidney disease on haemodialysis: A feasibility open trial.

Chan R, Dear BF, Titov N, Chow J, Suranyi M. Chan R, et al. J Psychosom Res. 2016 Oct;89:78-84. doi: 10.1016/j.jpsychores.2016.08.012. Epub 2016 Aug 29. J Psychosom Res. 2016. PMID: 27663114

10

Acute vascular access catheters for haemodialysis: complications limiting technique survival.

Jefferys A, Chow JS, Suranyi MG. Jefferys A, et al. Among authors: suranyi mg. Nephrology (Carlton). 2003 Feb;8(1):16-20. doi: 10.1046/j.1440-1797.2003.00139.x. Nephrology (Carlton). 2003. PMID: 15012745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters